Milky White of Small Size on Hand and Feet
Phase 4
- Conditions
- Health Condition 1: L80- Vitiligo
- Registration Number
- CTRI/2023/06/054258
- Lead Sponsor
- Prashant Srivastava
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ALL PATIENT HAVING ACRAL VITILIGO
PATIENT GIVING CONSENT
Exclusion Criteria
Pregnant and lactating females and patients with unrealistic expectation will not be included in this
study.
Patients with comorbid conditions such as tuberculosis, peptic ulcer disease, diabetes mellitus,
human immuno deficiency virus infection, herpes Zoster etc .
Concomitant treatment with topical steroids, topical calcineurin inhibitors, supplements (e.g.
Polypodium leucotomos and Ginkgo biloba), or phototherapy will not be allowed.
Patient who are not willing to participate in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To Study the efficacy of 2% Tofacitnib gel in acral vitligo patientsTimepoint: 4 WEEK 8 WEEK 12 WEEK 16 WEEK 20 WEEK 24 WEEK
- Secondary Outcome Measures
Name Time Method To study the safety of 2% Tofacitinib gel in acral vitiligo patientsTimepoint: 4 WEEK 8 WEEK 12 WEEK 16 WEEK 20 WEEK 24 WEEK